Hereditary defect of apolipoprotein B 100 – analysis of group of patients treated with standard peroral lipid-lowering therapy in St. Anne's University Hospital Brno

Atherosclerosis ◽

10.1016/j.atherosclerosis.2016.07.348 ◽

2016 ◽

Vol 252 ◽

pp. e36

Author(s):

O. Kyselak ◽

V. Soska

Keyword(s):

Apolipoprotein B ◽

University Hospital ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy ◽

Hereditary Defect

Download Full-text

Low-Density Lipoprotein, Non–High-Density Lipoprotein, and Apolipoprotein B as Targets of Lipid-Lowering Therapy

Circulation ◽

10.1161/01.cir.0000074259.01696.c6 ◽

2003 ◽

Vol 107 (20) ◽

Author(s):

W.E. Feeman

Keyword(s):

High Density Lipoprotein ◽

Apolipoprotein B ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

High Density ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Low Density ◽

Lowering Therapy

Download Full-text

Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy

European Heart Journal ◽

10.1093/eurheartj/ehi077 ◽

2004 ◽

Vol 26 (3) ◽

pp. 210-212 ◽

Cited By ~ 44

Author(s):

Göran Walldius ◽

Ingmar Jungner

Keyword(s):

Apolipoprotein B ◽

Cardiac Risk ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Apolipoprotein A ◽

Lowering Therapy

Download Full-text

Erratum to “Apolipoprotein B levels in adults with Type 1 diabetes not receiving lipid-lowering therapy” [Clinical Biochemistry, Volume 42 (2009) 1218–1221]

Clinical Biochemistry ◽

10.1016/j.clinbiochem.2010.03.007 ◽

2010 ◽

Vol 43 (9) ◽

pp. 791

Author(s):

Adel B. Mazanderani ◽

Stephanie J. Wise ◽

Hugh D. Tildesley

Keyword(s):

Type 1 Diabetes ◽

Apolipoprotein B ◽

Clinical Biochemistry ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy

Download Full-text

Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B

The Endocrinologist ◽

10.1097/00019616-199104000-00025 ◽

1991 ◽

Vol 1 (2) ◽

pp. 138

Author(s):

&NA;

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Apolipoprotein B ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy ◽

Artery Disease

Download Full-text

1.P.279 Effect of XbaI polymorphism of apolipoprotein B gene on response to lipid lowering therapy in type II hypercholesterolemic patients

Atherosclerosis ◽

10.1016/s0021-9150(97)88458-4 ◽

1997 ◽

Vol 134 (1-2) ◽

pp. 75

Author(s):

P. Ye ◽

Y.Z. Shang ◽

S.W. Wang ◽

X.Y. Liu

Keyword(s):

Apolipoprotein B ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Type Ii ◽

Lowering Therapy ◽

Xbai Polymorphism ◽

Apolipoprotein B Gene

Download Full-text

Total plasma apolipoprotein B-100 levels: a possible efficacy marker for lipid lowering therapy in patients with familial combined hyperlipidemia

Atherosclerosis Supplements ◽

10.1016/s1567-5688(01)80218-x ◽

2001 ◽

Vol 2 (2) ◽

pp. 88

Author(s):

V.G. Athyros ◽

A.A. Papageorgiou ◽

D.S. Demitriadis ◽

I.G. Minovgidis ◽

A.G. Kontopoulos

Keyword(s):

Apolipoprotein B ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Total Plasma ◽

Familial Combined Hyperlipidemia ◽

Lowering Therapy ◽

Plasma Apolipoprotein

Download Full-text

Apolipoprotein B levels in adults with type 1 diabetes not receiving lipid-lowering therapy

Clinical Biochemistry ◽

10.1016/j.clinbiochem.2009.05.013 ◽

2009 ◽

Vol 42 (12) ◽

pp. 1218-1221 ◽

Cited By ~ 4

Author(s):

Adel B. Mazanderani ◽

Stephanie J. Wise ◽

Hugh D. Tildesley

Keyword(s):

Type 1 Diabetes ◽

Apolipoprotein B ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy

Download Full-text

Apolipoprotein B levels in adults with type 1 diabetes not receiving lipid-lowering therapy

Canadian Journal of Diabetes ◽

10.1016/s1499-2671(09)33150-0 ◽

2009 ◽

Vol 33 (3) ◽

pp. 242

Author(s):

H. Tildesley ◽

A. Mazanderani ◽

S. Wise

Keyword(s):

Type 1 Diabetes ◽

Apolipoprotein B ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Lowering Therapy

Download Full-text

Low-Density Lipoprotein, Non-High-Density Lipoprotein, and Apolipoprotein B as Targets of Lipid-Lowering Therapy

Circulation ◽

10.1161/01.cir.0000038419.53000.d6 ◽

2002 ◽

Vol 106 (20) ◽

pp. 2526-2529 ◽

Cited By ~ 209

Author(s):

Scott M. Grundy

Keyword(s):

High Density Lipoprotein ◽

Apolipoprotein B ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

High Density ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Low Density ◽

Lowering Therapy

Download Full-text

Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol

Journal of the American College of Cardiology ◽

10.1016/0735-1097(94)90635-1 ◽

1994 ◽

Vol 23 (4) ◽

pp. 899-906 ◽

Cited By ~ 45

Author(s):

B.Fendley Stewart ◽

B.Greg Brown ◽

Xue-Qiao Zhao ◽

Lynn A. Hillger ◽

Alan D. Sniderman ◽

...

Keyword(s):

Apolipoprotein B ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Lowering Therapy ◽

Very High

Download Full-text